Home
Team
Blog
Experts
Careers
Projects
Code of Conduct
Press
Publications
Contact Us
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
Do you recommend routine use of Evusheld for pre-exposure prophylaxis for patients on immunosuppression?
When would you consider checking JC virus prior to initiating biologic therapy?
Should we feel comfortable starting anti-TNF therapy in an otherwise low risk patient with borderline IGRA?
Do you recommend re-vaccination in immunosuppressed patients who completed hepatitis B vaccine series but are found to have undetectable or low surface antibody titers?
Is there a role for antibody testing to confirm vaccine response for patients on rituximab after COVID-19 vaccination?
Do you hold tocilizumab for patients who are diagnosed with Covid and are with mild to moderate symptoms or non-hospitalized?
Have alterations in autoimmune antibody profiles been observed in rheumatic disease patients who have had Covid-19?
How are you timing the third dose of the COVID-19 mRNA vaccine in patients on rituximab?
Which medications have the lowest risk of tuberculosis reactivation in patients with uncertain tuberculosis history and active rheumatologic disease?
Do you recommend COVID-19 antibody testing after vaccination in individuals on immunomodulatory medications?
